PRIMROSE THERAPEUTICS

primrose-therapeutics-logo

Primrose Therapeutics, Inc. is a biotechnology company focused on the development of treatments for Polycystic Kidney Disease (PKD). PKD is one of the most common life-threatening genetic disorders, affecting 600,000 Americans and 12.5 million people worldwide -- more than cystic fibrosis, muscular dystrophy, hemophilia, Down syndrome and sickle cell anemia combined. PKD results in the abnormal growth of cells in the kidney, which eventually lead to the development of bilateral kidney cysts and structural destruction of the kidney. The average lifespan of PKD patients is 64 years -- at least a decade shorter than average. No FDA approved therapies currently exist for this devastating disease.

#People #Website #More

PRIMROSE THERAPEUTICS

Industry:
Biotechnology Medical Therapeutics

Founded:
2010-01-01

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.primrosetherapeutics.com

Total Employee:
1+

Status:
Active

Contact:
212-632-5404

Email Addresses:
[email protected]

Total Funding:
752.55 K USD

Technology used in webpage:
Domain Not Resolving


Current Employees Featured

not_available_image

Zachary S. Sharon
Zachary S. Sharon CEO @ Primrose Therapeutics
CEO

not_available_image

Mark Kessel
Mark Kessel Executive Officer @ Primrose Therapeutics
Executive Officer

Founder


eric-rowinsky_image

Eric Rowinsky

Official Site Inspections

http://www.primrosetherapeutics.com

Unable to get host informations!!!

Loading ...

More informations about "Primrose Therapeutics" on Search Engine